Publication:
Correlation Between Intrahepatic Hepatitis B Virus cccDNA Levels and Other Activity Markers in Patients with HBeAg-Negative Chronic Hepatitis B Infection

dc.authorscopusid36981727800
dc.authorscopusid57204080929
dc.authorscopusid11539128500
dc.authorscopusid7003962239
dc.authorscopusid6603440977
dc.authorscopusid6603335543
dc.authorscopusid36886143600
dc.contributor.authorGüner, R.
dc.contributor.authorKarahocagil, M.
dc.contributor.authorBüyükberber, M.
dc.contributor.authorKandemir, O.
dc.contributor.authorUral, O.
dc.contributor.authorUsluer, G.
dc.contributor.authorİNan, D.
dc.date.accessioned2020-06-21T14:29:53Z
dc.date.available2020-06-21T14:29:53Z
dc.date.issued2011
dc.departmentOndokuz Mayıs Üniversitesien_US
dc.department-temp[Güner] Rahmet, Department of Infectious Diseases and Clinical Microbiology, Ataturk Training and Research Hospital, Izmir, Turkey; [Karahocagil] Mustafa Kasım, Department of Infectious Diseases and Clinical Microbiology, Van Yüzüncü Yıl Üniversitesi, Van, Turkey; [Büyükberber] Mehmet, Department of Gastroenterology, Van Yüzüncü Yıl Üniversitesi, Van, Turkey; [Kandemir] Özlem, Department of Infectious Diseases and Clinical Microbiology, Mersin Üniversitesi, Mersin, Turkey; [Ural] Onur, Department of Infectious Diseases and Clinical Microbiology, Selçuk Üniversitesi, Selçuklu, Konya, Turkey; [Usluer] Gaye, Department of Infectious Diseases and Clinical Microbiology, Eskişehir Osmangazi Üniversitesi, Eskisehir, Eskisehir, Turkey; [İNan] Dilara, Department of Infectious Diseases and Clinical Microbiology, Akdeniz Üniversitesi, Antalya, Turkey; [Köksal] Iftíhar, Department of Infectious Diseases and Clinical Microbiology, Karadeniz Technical University, Trabzon, Trabzon, Turkey; [Baykam] Nurcan (n), Department of Infectious Diseases and Clinical Microbiology, Ankara Numune Education and Research Hospital, Ankara, Turkey; [Hızel] Kenan, Department of Infectious Diseases and Clinical Microbiology, Gazi Üniversitesi, Ankara, Ankara, Turkey; [Yamazhan] Tansu, Department of Infectious Diseases and Clinical Microbiology, Ege Üniversitesi, Izmir, Turkey; [Esen] Şaban, Department of Infectious Diseases and Clinical Microbiology, Ondokuz Mayis Üniversitesi, Samsun, Turkey; [Taşyaran] Mehmet Akin, Department of Infectious Diseases and Clinical Microbiology, Ataturk Training and Research Hospital, Izmir, Turkeyen_US
dc.description.abstractOBJECTIVE: The aim of this study was to demonstrate the relation between intrahepatic (IH) hepatitis B virus (HBV) covalently closed circular DNA (cccDNA) levels and the other HBV replicative intermediates and hepatocyte expression of HBV antigens. PATIENTS AND METHODS: Patients with hepatitis B surface antigen (HBsAg) positivity, hepatitis B early antigen negativity, serum HBV DNA levels 10 copies/ml or more, and constantly or intermittently increased alanine aminotransferase levels were included. RESULTS: Fifty-nine patients were included. There was a good correlation between the levels of IH HBV cccDNA and serum HBV DNA (P<0.001). Serum HBsAg levels were weakly correlated with IH HBV cccDNA levels and moderately correlated with serum HBV DNA (r=0.322, P=0.017; r=0.489, P=0.001, respectively). There were no significant correlation between serum HBsAg level and histologic activity index groups (P=0.691), but stage 0, 1, and greater than 2 fibrosis groups were positively correlated with serum HBsAg levels (P=0.019). IH cccDNA and serum HBV DNA were significantly different in hepatitis B core antigen staining groups (P=0.008 and <0.001, respectively) but there was no significant correlation between HBsAg staining groups and HBV replication markers. There was a weak correlation between serum HBsAg levels and IH HBsAg and hepatitis B core antigen levels (r=0.333, P=0.012; r=0.366, P=0.006, respectively). In multivariate analysis, alanine aminotransferase, age, fibrosis stage, and serum HBsAg quantitation were the most important factors predicting IH HBV cccDNA level. CONCLUSION: Histopathologic damage, serum HBV DNA levels, and IH HBV replication markers have a more complex and dynamic process. However, both serum and IH HBV replication markers provide important knowledge about the activity of the disease. © 2011 Wolters Kluwer Health | Lippincott Williams &Wilkins.en_US
dc.identifier.doi10.1097/MEG.0b013e32834ba13a
dc.identifier.endpage1191en_US
dc.identifier.issn1473-5687
dc.identifier.issue12en_US
dc.identifier.pmid21934508
dc.identifier.scopus2-s2.0-80955123640
dc.identifier.scopusqualityQ2
dc.identifier.startpage1185en_US
dc.identifier.urihttps://doi.org/10.1097/MEG.0b013e32834ba13a
dc.identifier.volume23en_US
dc.identifier.wosWOS:000296752100014
dc.identifier.wosqualityQ3
dc.language.isoenen_US
dc.publisherLippincott Williams & Wilkinsen_US
dc.relation.ispartofEuropean Journal of Gastroenterology & Hepatologyen_US
dc.relation.journalEuropean Journal of Gastroenterology & Hepatologyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectHepatitis B Core Antigenen_US
dc.subjectHepatitis B Early Antigen-Negative Chronic Hepatitisen_US
dc.subjectHepatitis B Surface Antigenen_US
dc.subjectHepatitis B Virusen_US
dc.subjectHepatitis B Virus Covalently Closed Circular DNAen_US
dc.subjectImmunohistochemistryen_US
dc.subjectQuantitative Hepatitis B Surface Antigenen_US
dc.titleCorrelation Between Intrahepatic Hepatitis B Virus cccDNA Levels and Other Activity Markers in Patients with HBeAg-Negative Chronic Hepatitis B Infectionen_US
dc.typeArticleen_US
dspace.entity.typePublication

Files